 MELBOURNE, Australia, Feb. 11, 2021 PRNewswire -- Starpharma ASX: SPL, OTCQX: SPHRY today announced that is has signed a Research Agreement with MSD, the tradename of Merck Co., Inc., Kenilworth NJ USA. Under the agreement, MSD will conduct a preclinical research evaluation of... 